Resistance to non-nucleoside inhibitors of HIV-1 reverse transcriptase
- 28 February 1999
- journal article
- Published by Elsevier in Drug Resistance Updates
- Vol. 2 (1), 56-67
- https://doi.org/10.1054/drup.1998.0064
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Short Communication: Lamivudine Resistance of HIV Type 1 Does Not Delay Development of Resistance to Nonnucleoside HIV Type 1-Specific Reverse Transcriptase Inhibitors as Compared with Wild-Type HIV Type 1AIDS Research and Human Retroviruses, 1998
- Resistance to nevirapine of HIV-1 reverse transcriptase mutants: loss of stabilizing interactions and thermodynamic or steric barriers are induced by different single amino acid substitutionsJournal of Molecular Biology, 1997
- Characterization of the Reverse Transcriptase of a Human Immunodeficiency Virus Type 1 Group O IsolateVirology, 1997
- Efficacy, Pharmacokinetics, andin VivoAntiviral Activity of UC781, a Highly Potent, Orally Bioavailable Nonnucleoside Reverse Transcriptase Inhibitor of HIV Type 1AIDS Research and Human Retroviruses, 1997
- Crystal Structures of 8-Cl and 9-Cl TIBO Complexed with Wild-type HIV-1 RT and 8-Cl TIBO Complexed with the Tyr181Cys HIV-1 RT Drug-resistant MutantJournal of Molecular Biology, 1996
- HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation TimeScience, 1996
- Simultaneous mutations at Tyr‐181 and Tyr‐188 in HIV‐1 reverse transcriptase prevents inhibition of RNA‐dependent DNA polymerase activity by the bisheteroarylpiperazine (BHAP) U‐90152sFEBS Letters, 1995
- HIV-1 group O sensitivity to antiretroviral drugsAIDS, 1995
- Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infectionNature, 1995
- Viral dynamics in human immunodeficiency virus type 1 infectionNature, 1995